Mark R. DeFazio Honored at Grand Opening of Boro Park JCC Community Center
Metropolitan Commercial Bank’s CEO Front and Center Celebrating Expansion and Community Impact NEW YORK–(BUSINESS WIRE)–#mcb–Mark R. DeFazio,... Read more.
Dentalcorp Declares Dividend and Announces Release Date for Third Quarter 2025 Results
TORONTO–(BUSINESS WIRE)–dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company”) (TSX: DNTL), Canada’s largest and one of North America’s... Read more.
KalVista Pharmaceuticals Announces European Commission and Swissmedic Approval of EKTERLY® (sebetralstat), First and Only Oral On-Demand Treatment for Hereditary Angioedema
First European launch of EKTERLY expected in Germany Q4 2025 EKTERLY now approved in the US, EU, UK and Switzerland with additional regulatory applications under... Read more.
New MindMed Retrospective Study Presented at Psych Congress 2025 Reveals High Rates of Suicidal Ideation (SI) in Adults with Generalized Anxiety Disorder (GAD)
Nearly 50% of individuals with severe GAD reported experiencing SI almost daily Findings highlight the link between anxiety severity and SI, underscoring the need... Read more.
United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will host... Read more.
TRYNGOLZA® (olezarsen) approved in the European Union for familial chylomicronemia syndrome (FCS)
CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) and Sobi® today announced that TRYNGOLZA® (olezarsen) has been approved... Read more.
European Commission (EC) Approves Henlius and Organon’s BILDYOS® (denosumab) and BILPREVDA® (denosumab), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively
SHANGHAI & JERSEY CITY, N.J.–(BUSINESS WIRE)–Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced the European Commission... Read more.
Macquarie Asset Management Reaches $US3 Billion Close of Green Energy Transition Solutions Fund and Co-Investment Commitment
LONDON & NEW YORK–(BUSINESS WIRE)–Macquarie Asset Management today announced the final close of Macquarie Green Energy Transition Solutions (“MGETS”... Read more.
Persistent gaps in risk and adaptation strategies remain amid rising climate hazards
NEW YORK–(BUSINESS WIRE)–New research published today by Marsh, the world’s leading insurance broker and risk advisor and a business of Marsh McLennan... Read more.
KBRA Releases Research – Financing the Field: Credit Dynamics in Football Stadiums
DUBLIN–(BUSINESS WIRE)–#creditratingagency–KBRA releases research examining the structural and credit considerations of European football stadium... Read more.